Skip to main content

Gadoxetate disodium Side Effects

Medically reviewed by Drugs.com. Last updated on Mar 15, 2024.

Applies to gadoxetate disodium: intravenous solution.

Warning

Intravenous route (Solution)

Gadolinium-based contrast agents (GBCAs) increase the risk for nephrogenic systemic fibrosis (NSF) in patients with impaired elimination of the drugs. Patients with chronic, severe renal insufficiency (GFR less than 30 mL/min/1.73 m(2)) or acute kidney injury are at greatest risk. NSF may lead to fatal or debilitating systemic fibrosis affecting the skin, muscle, and internal organs. Avoid use of GBCAs in patients with impaired elimination unless use is essential and other modalities (eg, non-contrast enhanced MRI) are not available. Screen for acute kidney injury and other conditions that may reduce renal function. For patients at risk for chronically reduced renal function (eg, age greater than 60 years, hypertension, or diabetes), perform lab testing to estimate the GFR. For patients with the highest NSF risk, do not exceed the recommended dose and allow enough time for drug elimination prior to any readministration.

Serious side effects of Gadoxetate disodium

Along with its needed effects, gadoxetate disodium may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking gadoxetate disodium:

Rare

Incidence not known

Other side effects of Gadoxetate disodium

Some side effects of gadoxetate disodium may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Rare

For Healthcare Professionals

Applies to gadoxetate disodium: intravenous solution.

Cardiovascular

Cardiovascular side effects have included chest pain, bundle branch block, increased blood pressure, and flushing.[Ref]

Nervous system

Nervous system side effects have included headache, akathisia, dizziness, parosmia, vertigo, tremor, akathisia, and dysgeusia.[Ref]

Respiratory

Respiratory side effects have included dyspnea and respiratory distress.[Ref]

Gastrointestinal

Gastrointestinal side effects have included dry mouth, oral discomfort, salivary hypersecretion, nausea, and vomiting.[Ref]

General

General side effects have included feeling hot, chills, discomfort, fatigue and malaise.[Ref]

Dermatologic

Dermatologic side effects have included maculopapular rash, hyperhidrosis, rash, and pruritus.[Ref]

Local

Local side effects have included injection site reactions (pain, burning, coldness, extravasation).[Ref]

References

1. Product Information. Eovist (gadoxetate). Bayer Pharmaceutical Inc. 2008.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.